LENVATINIB IMPROVES PROGRESSION FREE SURVIVAL IN PATIENTS WITH INTERMEDIATE STAGE HEPATOCELLULAR CARCINOMA AFTER TRANSCATHETER ARTERIAL CHEMOEMBOLIZATION

被引：0
|
作者：
Shimose, Shigeo [1 ]
Kawaguchi, Takumi [1 ]
Iwamoto, Hideki [1 ]
Nakano, Masahito [1 ]
Takashi, Niizeki [1 ]
Shirono, Tomotake [1 ]
Tanaka, Masatoshi [2 ]
Koga, Hironori [1 ]
Torimura, Takuji [1 ]
机构：
[1] Kurume Univ, Sch Med, Dept Med, Div Gastroenterol, Kurume, Fukuoka, Japan
[2] Yokokura Hosp, Miyama, Fukuoka, Japan
来源：
HEPATOLOGY | 2019年 / 70卷
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
367
引用
收藏
页码：233A / 234A
页数：2
相关论文
共 50 条
  • [21] Postoperative adjuvant transcatheter arterial chemoembolization improves the prognosis of patients with huge hepatocellular carcinoma
    Wang, Han
    Yu, Hua
    Qian, You-Wen
    Cao, Zhen-Ying
    Wu, Meng-Chao
    Cong, Wen-Ming
    HEPATOBILIARY & PANCREATIC DISEASES INTERNATIONAL, 2021, 20 (03) : 232 - 239
  • [22] Transcatheter arterial chemoembolization in hepatocellular carcinoma
    Farinati, F
    Rinaldi, M
    Gianni, S
    Marin, G
    HEPATOLOGY, 1998, 28 (05) : 1441 - 1442
  • [23] A Radiomics Signature-Based Nomogram to Predict the Progression-Free Survival of Patients With Hepatocellular Carcinoma After Transcatheter Arterial Chemoembolization Plus Radiofrequency Ablation
    Fang, Shiji
    Lai, Linqiang
    Zhu, Jinyu
    Zheng, Liyun
    Xu, Yuanyuan
    Chen, Weiqian
    Wu, Fazong
    Wu, Xulu
    Chen, Minjiang
    Weng, Qiaoyou
    Ji, Jiansong
    Zhao, Zhongwei
    Tu, Jianfei
    FRONTIERS IN MOLECULAR BIOSCIENCES, 2021, 8
  • [24] Improved survival with resection after transcatheter arterial chemoembolization (TACE) for unresectable hepatocellular carcinoma
    Fan, J
    Tang, ZY
    Yu, YQ
    Wu, ZQ
    Ma, ZC
    Zhou, XD
    Zhou, J
    Qiu, SJ
    Lu, JZ
    DIGESTIVE SURGERY, 1998, 15 (06) : 674 - 678
  • [25] Randomized clinical trial of transcatheter arterial chemoembolization plus radiofrequency ablation versus transcatheter arterial chemoembolization for hepatocellular carcinoma with intermediate stage (BCLC stage B) hepatocellular carcinoma beyond Milan criteria.
    Yin, Xin
    Tang, Bei
    Gan, Yu-Hong
    Wang, Yan-hong
    Chen, Yi
    Ge, Ning-lin
    Chen, Rongxin
    Zhang, Lan
    Zhang, Boheng
    Ren, Zhenggang
    JOURNAL OF CLINICAL ONCOLOGY, 2019, 37 (15)
  • [26] Effect of Lenvatinib and bevacizumab on hepatocellular carcinoma after hepatic arterial chemoembolization
    Liu, Fenghao
    Ma, Zhongguang
    Zhou, Zhenzhen
    Li, Xuefeng
    INTERNATIONAL JOURNAL OF CLINICAL AND EXPERIMENTAL MEDICINE, 2023, 16 (01): : 8 - 14
  • [27] Prognostic nomogram for patients with unresectable hepatocellular carcinoma after transcatheter arterial chemoembolization
    Xu, Li
    Peng, Zhen-Wei
    Chen, Min-Shan
    Shi, Ming
    Zhang, Yao-Jun
    Guo, Rong-Ping
    Lin, Xiao-Jun
    Lau, Wan-Yee
    JOURNAL OF HEPATOLOGY, 2015, 63 (01) : 122 - 130
  • [28] Transcatheter Arterial Chemoembolization for Unresectable Hepatocellular Carcinoma: Recent Progression and Perspective
    Takayasu, Kenichi
    ONCOLOGY, 2013, 84 : 28 - 33
  • [29] Analysis of survival factors in patients with intermediate-advanced hepatocellular carcinoma treated with transcatheter arterial chemoembolization combined with sorafenib
    Zheng, J.
    Shao, G.
    Luo, J.
    CLINICAL & TRANSLATIONAL ONCOLOGY, 2014, 16 (11): : 1012 - 1017
  • [30] Analysis of survival factors in patients with intermediate-advanced hepatocellular carcinoma treated with transcatheter arterial chemoembolization combined with sorafenib
    J. Zheng
    G. Shao
    J. Luo
    Clinical and Translational Oncology, 2014, 16 : 1012 - 1017
12345